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The high incidence of de novo chromosomal aberrations in a population of persons with autism suggests a causal relationship
between certain chromosomal aberrations and the occurrence of isolated idiopathic autism. We report on the clinical and
cytogenetic ﬁndings in a male patient with autism, no physical abnormalities and a de novo balanced (7;16)(p22.1;p16.2)
translocation. G-banded chromosomes and ﬂuorescent in situ hybridization (FISH) were used to examine the patient’s karyotype
as well as his parents’. FISH with speciﬁc RP11-BAC clones mapping near 7p22.1 and 16p11.2 was used to reﬁne the location of
the breakpoints. This is, in the best of our knowledge, the ﬁrst report of an individual with autism and this speciﬁc chromosomal
aberration.
Copyright © 2008 Nadia Bayou et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Autism is a relatively common and heterogeneous neuropsy-
chiatric disorder characterised by reduced social and interi-
ndividual contacts and interactions. Autism usually starts in
early childhood. Complete absence of eye contact and speech
c a nb eo b s e r v e di ns e v e r ef o r m so fa u t i s m[ 1]. Its incidence
is estimated at about 1/1000 to 1/2000 with a biased male-
to-female ratio of three or four to one (3-4 : 1) [2]. Studies
of familial cases have demonstrated that genetic factors are
involvedintheaetiologyofautism[3].Anumberofbalanced
and unbalanced chromosomal aberrations have been found
to be associated with autism [4–6].
In this study, we describe a reciprocal translocation
t(7;16)(p22.1;p11.2) that occurred de novo in a 10-year-
old boy with autism and psychomotor retardation and only
minor additional anomalies or dysmorphic features. Neither
chromosomal breakpoint has been mentioned in previous
reports of cytogenetic aberrations seen in patients with
autistic behaviour.
2. CASE REPORT
The 10-year-old patient is the younger of two children born
attermfromnonconsanguineous healthyparents. Thefather
and the mother were, respectively, 34 and 30years old when
the child was born. Pregnancy was uneventful. Delivery
was by caesarean section secondary to a narrow basin.
Birth weight was 3350kg, and no recognized malformations
were noted. His older sister is healthy and developmentally
normal.
Patient’s psychomotor delays were noticed in the ﬁrst
months of life by his parents; they also reported frequent
cryingandsleepdisturbances.Hewasunabletomaintaineye
contactandpresentedmanymotorstereotypesandritualistic
behaviours such as cutting papers into small pieces and
aligning objects. Clinical assessment showed a boy with no
dysmorphic signs (see Figure 1).
At the age of 4years and 11months, the patient was exa-
mined by an experienced child psychiatrist who found impa-
irments in social interaction and communication according2 Journal of Biomedicine and Biotechnology
to the Diagnostic and Statistical Manual-revision 4 (DSM-
IV) and the Autism Diagnostic Interview (ADI-R), French
version 1993, criteria and made the clinical diagnosis of
autism.
Routine hearing tests and amino acid chromatography
were normal. Brain CT scan revealed a cerebellar mega-
cysterna in the posterior fossa and a temporal arachnoidal
cyst. The electroencephalogram was normal. Southern blot
analysis revealed the absence of FRAXA mutation.
3. MATERIALS AND METHODS
Chromosomal abnormalities have been identiﬁed by using
traditional cytogenetics and ﬂuorescent in situ hybridization
(FISH).
Chromosomes were prepared from phytohemagglutinin
(PHA) stimulated peripheral blood lymphocytes of the
proband and his parents following standard procedures. The
healthy sister was not available for analysis. All chromosome
preparations were G-banded and then analysed.
For FISH analysis, metaphase spreads obtained from an
Epstein Barr virus (EBV) immortalised cell line from the
patient were hybridised with bacterial artiﬁcial chromosome
clones (BACs). The RPCI-11 BAC clones covering genomic
regions on both chromosomes were selected according to the
UCSCGenomebrowser(http://www.genome.ucsc.edu/)and
Ensembl genome database (http://www.ensembl.org/Homo
sapiens/). They were provided by BACPAC resource centre
(BPRC) (http://bacpac.chori.org) and professor Mariano
Rocchi (University of Bari, Italy). Thesequence limits of
the BACs were deﬁned according to DECIPHER database
(https://enigma.sanger.ac.uk/perl/PostGenomics/decipher).
BAC clones were biotinylated with biotin-11-dUTP
(Sigma) by nick translation using the Bio Nick labelling
system (Invitrogen Life Technologies). For the double colour
FISH experiment, one probe was labelled with biotin-11-
dUTP and the second probe, a commercially one, with
Rhodamine (QBiogen).
4. RESULTS
Routine and high-resolution chromosome studies revealed
a de novo translocation carried by the proband. The G-
band pattern suggested a balanced translocation involving
7p22 and 16p11.2 and established the karyotype as
46,XY,t(7;16)(p22; p11) (see Figure 2). The parent kary-
otypes were normal. To identify the translocation break-
points, we used 16 bacterial artiﬁcial chromosome clones
(BACS) from 7p22 and 16p11 in ﬂuorescence in situ
hybridization (FISH) analysis (see Table 1).
As shown in Figure 3(a), the RP11-730B22 BAC hybri-
dized to both derivative 7 and the derivative 16 and the nor-
mal chromosome 7, but not to the normal chromosome 16,
indicating that this clone spans the translocation breakpoint
on chromosome 7.
Although we did not identify the actual sequence of the
breakpoint on 7p22.1, we located it by BAC-FISH mapping
between nucleotides 4933257 and 5107654.












Figure 2: Partial GTG-banding karyotype of the patient. The
patient derivative chromosomes 7 and 16 are shown. By comparing
both respective ideogrammed chromosomes, the breakpoints were
located in 7p22 and 16p11.2.
According to Ensembl genome database (May 2006 vers-
ion), there are 3 coding sequences corresponding to
NP 976327.1, RBAK (RB-associated KRAB zinc ﬁnger) and
RNF216L or Q6NUR6 (E3 UBIQUITIN LIGASE TRIAD3
EC6.3.2.) genes.
Seven but four BAC clones located on 16p11.2 gave two
distinct hybridization signals on the normal 16p and the
derivative 16 (see Table 1). The overlapping BAC, RP11-
264M14, hybridized to both derivative 16 and derivative 7
chromosomes and to the normal chromosome 16, but not




Genetic studies have yielded suggestive linkage and associa-
tiontoseveraldiﬀerentchromosomalregions,butuptonow,
the large number of association studies using a candidate
gene approach has had limited success [7–10]. As anNadia Bayou et al. 3
Table 1: FISH results using BAC clones on 7p and 16p regions.











368N21 16p11.2 29408699 29609853 − ++−
261H5 16p11.2 31120739 31307726 − ++−
120K18 16p11.2 31163677 31329206 − ++−
264M14 16p11.2 33282423 33452774 − +++
341P6 16p11.2 34263016 34452072 − +++
104C4 16p11.2 33362222 33555929 −− ++
488I20 16p11.2 34359841 34490213 −− ++
449P15 7p22.3 885103 1079306 + −−+
42B7 7p22.2 4126462 4281105 + −−+
33P21 7p22.1 4559141 4711177 + −−+
32P3 7p22.1 4711178 4751000 + −−+
160E17 7p22.1 4751001 4911018 + −−+
805D5 7p22.1 4911019 4933256 + −−+
730B22 7p22.1 4933257 5107654 ++ − +
147A22 7p22.1 5183822 5357984 ++ −−
1275H24 7p22.1 5427168 5510299 ++ −−
425P5 7p22.1 6233987 6446613 ++ −−
+: presence of the signal hybridization.
−: absence of the signal hybridization.













Figure 3: FISH analysis of the translocation breakpoints: (a) FISH analysis with the BAC RP11-730B22 (green) located in 7p22.1 and a
centromeric probe of chromosome 16 (red), shows that this BAC is spanning the breakpoint on chromosome 7. (b) FISH analysis with
BACs RP11-264M14 (green) showed that it spans the translocation breakpoint located on 16p11.2. It was hybridised with a chromosome 7
centromeric probe (red). (Chr.: chromosome, Der.: derivative).
alternative approach, the characterisation of diﬀerent types
of chromosomal abnormalities could result in the identiﬁca-
tion of candidate genes for autism [11, 12]. Chromosomal
abnormalities detected by cytogenetics or molecular cytoge-
netics are of major aid to locate relevant genes. About 3–5%
of autistic patients have a chromosome abnormality visible
with cytogenetic methods [13]. Almost all chromosomes
have been involved including translocations and inversions
resulting in disruption of genes at the breakpoints [14, 15].
Balanced chromosome rearrangements are observed at a
signiﬁcantly increased rate. Gillberg and Wahlstr¨ om [16], in
anepidemiologicalstudydoneon66individualswithautism
located in Sweden, found that less than 5% of the group
had major chromosomal abnormalities. The same rate was
found by Castermans et al. [17] when they karyotyped 525
individuals with idiopathic autism. This rate is much higher
than would be expected from a general population (1/2000
for a reciprocal translocation and 1/10000 for an inversion)4 Journal of Biomedicine and Biotechnology
Table 2: Autism related breakpoints on 7p22p and 16p11.2.
Chromosome Karyotype Phenotype Reference
Chr16 46, XX, dir dup(16)(p11.2p12.1) autism, mild mental retardation Finelli et al. [20]E n g e l e ne ta l .[ 21]
Chr16 46, XY, dir dup(16)(p11.2p12) de novo autistic behaviour, psychomotor retardation Carrasco Juan et al. [22]
Chr16 46, XY, inv(2)(p11.2q13), 16qh- autism Vorsanova et al. [23]
Chr7 del (7)(p22.2p22.2) autism Yu et al. [24]
[18]. This suggests that certain chromosome aberrations like
translocations, deletions, or inversions may involve genes
acting as susceptible factors for autism.
In this article, we describe a 10-year-old child carrying
a de novo balanced (7;16)(p22.1;p16.2) translocation associ-
ated with an autistic disorder, psychomotor delays, and no
dysmorphic features.
This case represents both an unusual and useful oppor-
tunity to examine and compare the cytogenetic and the
common physical features with the previously reported cases
ofautismandthesespeciﬁcregions.InTable 2,anoverviewis
given of all patients with chromosomal anomalies involving
the 7p22.1 and 16p11.2 regions that have been described
in the literature. In the best of our knowledge, it is the
ﬁrst time the autism phenotype has been associated with a
translocation in these speciﬁc chromosomal regions.
Chromosome 16p has been identiﬁed by a number of
genome screens for autism and is likely to contain an
autism-susceptibility variant. The 7p locus has been less
consistently reported than the chromosome 16p one. Both
regions remain an important area for future research [19].
Regarding the locus on 16p11.2, only duplications and
one inversion have been reported [20–23]. Looking at the
overall clinical phenotype of our patient and the literature
described ones, the only shared features seem to be autistic
behaviour. The observed phenotypic variety may be caused
by the dissimilarity in the nature of the chromosomal
abnormalities and by the size and the content of the interval.
Large-deletion alleles on chromosome 7p22 were found
in kindreds with autism but not in healthy control subjects
[24]. In these regions, genes are likely to contribute to
autism in the individuals with the cytogenetic abnormality
but appear to lack a signiﬁcant eﬀect at the population
level. More than 100genes have been mapped in the deleted
interval (http://genome.ucsc.edu/), and so it is only possible
to speculate about the potential role of speciﬁc genes in
autism.
According to Ensembl genome databases, there are
few genes listed in the breakpoint region on 7p22.1 :
NP 976327.1, which is a hypothetical gene expressed in the
cerebellum, RBAK gene may contribute to transcriptional
activation and cell cycle arrest and RNF216L or Q6NUR6
gene which may be an E3 ubiquitin ligase. On the basis of
their functions and expression patterns, these genes can be
considered as candidate genes for autism.
Interestingly, the disruption of one of these genes by the
translocation may cause a decreased dosage responsible for
speciﬁc tissue and developmental eﬀects leading to autistic
traits. This is in agreement with the deletions on 7p22
reported on autistic patients by Yu et al. [24].
Thecharacterisationofthetranslocationbreakpointswill
let as to narrow the interval and to identify candidate genes
causative of the observed phenotype in our patient.
In conclusion, the case report presented here (1) places
further emphasis on the importance of molecular cyto-
genetics in the study of de novo apparently balanced
translocations with abnormal phenotype and (2) conﬁrms
the possibility that genes with an important contribution
to the pathogenesis of autism are located in regions of the
genome for which cytogenetic abnormalities have not been
reported so far.
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